Neumora Therapeutics logo

Neumora Therapeutics share price today

(NMRA)

Neumora Therapeutics share price is $10.85 & ₹921.99 as on 21 Dec 2024, 2.30 'hrs' IST

$10.85

0.35

(3.33%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Neumora Therapeutics share price in Dollar and Rupees. Guide to invest in Neumora Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Neumora Therapeutics. Get details on the Indian mutual funds that are investing in Neumora Therapeutics. Get Analyst recommendations and forecasts along with all the Neumora Therapeutics's financials.

Neumora Therapeutics share price movements

  • Today's Low: $10.25
    Today's High: $11.09

    Day's Volatility :7.57%

  • 52 Weeks Low: $8.33
    52 Weeks High: $21.00

    52 Weeks Volatility :60.33%

Neumora Therapeutics Returns

PeriodNeumora Therapeutics, Inc.Index (Russel 2000)
3 Months
-15.1%
0.0%
6 Months
14.21%
0.0%
1 Year
-38.0%
0.0%
3 Years
-33.23%
-19.7%

Neumora Therapeutics Key Statistics

in dollars & INR

Previous Close
$10.5
Open
$10.17
Today's High
$11.09
Today's Low
$10.25
Market Capitalization
$1.7B
Today's Volume
$1.8M
52 Week High
$21.0
52 Week Low
$8.33
Revenue TTM
$0.0
EBITDA
$-250.0M
Earnings Per Share (EPS)
$-1.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-77.08%

How to invest in Neumora Therapeutics from India?

It is very easy for Indian residents to invest directly in Neumora Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neumora Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neumora Therapeutics or NMRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neumora Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neumora Therapeutics shares which would translate to 0.078 fractional shares of Neumora Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Neumora Therapeutics, in just a few clicks!

Returns in Neumora Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neumora Therapeutics investment value today

Current value as on today

₹1,40,196

Returns

₹40,196

(+40.2%)

Returns from Neumora Therapeutics Stock

₹38,000 (false-38%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Neumora Therapeutics

-22%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Neumora Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -22% less investors are searching Neumora Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Neumora Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Neumora Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Neumora Therapeutics

What analysts predicted

Upside of 118.29%

Current:

$10.85

Target:

$23.68

Insights on Neumora Therapeutics

  • Price Movement

    In the last 7 days, NMRA stock has moved up by 5.1%
  • NMRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 57.9%

Neumora Therapeutics Technicals Summary

Sell

Neutral

Buy

Neumora Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Neumora Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neumora Therapeutics, Inc.
11.97%
14.21%
-38.0%
-33.23%
-33.23%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neumora Therapeutics, Inc.
NA
NA
NA
-1.56
-0.77
-0.38
NA
2.38
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neumora Therapeutics, Inc.
Buy
$1.7B
-33.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Neumora Therapeutics

Organization
Neumora Therapeutics
Employees
124
CEO
Mr. Paul L. Berns
Industry
Miscellaneous

Management People of Neumora Therapeutics

NameTitle
Mr. Paul L. Berns
Co-Founder & Executive Chairman
Mr. Henry O. Gosebruch
President, CEO & Director
Mr. Jason G. Duncan J.D.
Chief Legal Officer
Mr. Robert Lenz M.D., Ph.D.
Head of Research & Development
Ms. Carol Suh
Co-Founder & COO
Dr. Joshua Pinto Ph.D.
Chief Financial Officer
Mr. Michael Lee Milligan
Principal Accounting Officer
Dr. Rajesh Manchanda Ph.D.
Chief Technical Operations Officer
Mr. Nicholas Brandon Ph.D.
Chief Scientific Officer
Amy Sullivan
Chief Human Resources Officer

Important FAQs about investing in Neumora Therapeutics from India :

What is Neumora Therapeutics share price today?

Neumora Therapeutics share price today stands at $10.85, Open: $10.17 ; Previous Close: $10.50 ; High: $11.09 ; Low: $10.25 ; 52 Week High: $21.00 ; 52 Week Low: $8.33. The stock opens at $10.17, after a previous close of $10.50. The stock reached a daily high of $11.09 and a low of $10.25, with a 52-week high of $21.00 and a 52-week low of $8.33.

Can Indians buy Neumora Therapeutics shares?

Yes, Indians can invest in the Neumora Therapeutics (NMRA) from India.

With INDmoney, you can buy Neumora Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neumora Therapeutics at zero transaction cost.

How can I buy Neumora Therapeutics shares from India?

It is very easy to buy Neumora Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neumora Therapeutics be purchased?

Yes, you can buy fractional shares of Neumora Therapeutics with INDmoney app.

What are the documents required to start investing in Neumora Therapeutics stocks?

To start investing in Neumora Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neumora Therapeutics

Today’s highest price of Neumora Therapeutics (NMRA) is $11.09.

Today’s lowest price of Neumora Therapeutics (NMRA) is $10.25.

What is today's market capitalisation of Neumora Therapeutics

Today's market capitalisation of Neumora Therapeutics NMRA is 1.7B

What is the 52 Week High and Low Range of Neumora Therapeutics

  • 52 Week High

    $21.00

  • 52 Week Low

    $8.33

What are the historical returns of Neumora Therapeutics?

  • 1 Month Returns

    11.97%

  • 3 Months Returns

    14.21%

  • 1 Year Returns

    -38%

  • 5 Years Returns

    -33.23%

Who is the Chief Executive Officer (CEO) of Neumora Therapeutics

Mr. Paul L. Berns is the current Chief Executive Officer (CEO) of Neumora Therapeutics.